DECT and PCT Imaging Biomarkers for Head and Neck Cancer Treatment Response

Benjamin Van Honacker conducted an exploratory study of 36 head and neck cancer patients. The dataset likely contains quantitative parameters from dual-energy and perfusion CT scans taken at baseline, 3 weeks, 3 months, and 12 months post-treatment. The data was collected to investigate associations with complete response to chemoradiotherapy.

Use Cases

• Predicting complete response to chemoradiotherapy based on perfusion CT parameters like blood flow and blood volume.
• Comparing imaging biomarker trajectories between HPV-positive and HPV-negative patient subgroups.
• Analyzing changes in contrast media attenuation over time as a potential indicator of treatment response.

Strengths

• Includes data from 36 patients, a sample size suitable for exploratory analysis.
• Contains longitudinal imaging data captured at four specific time points: baseline, 3 weeks, 3 months, and 12 months.
• Data is associated with a registered clinical trial (NCT04019548), providing a structured research context.

Limitations

• The dataset is very small (87.2 KB), indicating limited scope and likely a summary or document rather than raw patient-level data.
• Column-level documentation is absent; field semantics must be inferred after download.
• Row count is unknown, which may limit suitability assessment for machine learning tasks.

Provenance

Source

figshare

Collection Method

Data was collected from a clinical trial involving imaging scans of head and neck cancer patients.

Freshness

Last updated 2026-05-05 04:12:49; freshness should be verified.